Characterization of the mechanism by which the RB/E2F pathway controls expression of the cancer genomic DNA deaminase APOBEC3B.

MLA

Roelofs, Pieter A., et al. “Characterization of the Mechanism by Which the RB/E2F Pathway Controls Expression of the Cancer Genomic DNA Deaminase APOBEC3B.” ELife, vol. 9, Sept. 2020. EBSCOhost, https://doi.org/10.7554/eLife.61287.

APA

Roelofs, P. A., Goh, C. Y., Chua, B. H., Jarvis, M. C., Stewart, T. A., McCann, J. L., McDougle, R. M., Carpenter, M. A., Martens, J. W., Span, P. N., Kappei, D., & Harris, R. S. (2020). Characterization of the mechanism by which the RB/E2F pathway controls expression of the cancer genomic DNA deaminase APOBEC3B. ELife, 9. https://doi.org/10.7554/eLife.61287

Chicago

Roelofs, Pieter A, Chai Yeen Goh, Boon Haow Chua, Matthew C Jarvis, Teneale A Stewart, Jennifer L McCann, Rebecca M McDougle, et al. 2020. “Characterization of the Mechanism by Which the RB/E2F Pathway Controls Expression of the Cancer Genomic DNA Deaminase APOBEC3B.” ELife 9 (September). doi:10.7554/eLife.61287.